Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.45 |
| ▸ | JAK2 | O60674 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
| ▸ | AMY1A | P0DUB6 | 4/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imidazole SCHEMBL28300497 | 0.83 | ALDH1A1 (0.45) | ALDH1A1FKBP5CYP19A1CA12CA1 | |
| SCHEMBL3790244 | 0.77 | CA1 (0.58) | ALDH1A1JAK2AMY1ACA12CA1 | |
| Imidazole SCHEMBL3868275 | 0.72 | ALDH1A1 (0.45) | ALDH1A1FKBP5CA1CA2ADRA2A | |
| Imidazole SCHEMBL5246988 | 0.72 | — | — | |
| 1,2-Dichlorobenzene SCHEMBL27574752 | 0.71 | ALDH1A1 (0.59) | ALDH1A1FKBP5JAK2CYP19A1KDM4E | |
| 1,4-Dichlorobenzene SCHEMBL27574751 | 0.71 | ALDH1A1 (0.65) | ALDH1A1FKBP5CYP19A1CYP11B1CYP11B2 | |
| Chlorobenzene SCHEMBL17583808 | 0.70 | ALDH1A1 (0.56) | ALDH1A1FKBP5CYP19A1KDM4ELMNA | |
| Imidazole SCHEMBL1164212 | 0.70 | — | — | |
| Imidazole SCHEMBL28633592 | 0.69 | — | — | |
| Imidazole SCHEMBL28604480 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9334297-B2 | Chiral imidazolium salts for asymmetric catalysis | NORTHWESTERN UNIVERSITY (US) | 2016-05-10 | — | — | US | disclosed |
| US-20160075728-A1 | Chiral Imidazolium Salts for Asymmetric Catalysis | NATIONAL SCIENCE FOUNDATION | 2016-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075728-A1 | Chiral Imidazolium Salts for Asymmetric Catalysis | NDC1, NUDC, NIT2 | ALDH1A1 2659/4885FKBP5 1428/4885JAK2 3059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.